| L |
|
LABORATORY CHARACTERISTICS OF WOMEN WITH MENORRHAGIA: A MULTI-SITE U.S. STUDY
|
| Miller C.H., Heit J.A., Kouides P.A., Lukes A.S., Philipp C.S., Stein S.F., Dowling N., Byams V.R., Rawlins P., Kulkarni R. |
| |
|
LABORATORY DIAGNOSIS AND MONITORING OF DDAVP TREATMENT OF VON WILLEBRAND DISEASE BY FLOW CYTOMETRY
|
| Giannini S., Mezzasoma A., Leone M., Gresele P. |
| |
|
LABORATORY DIAGNOSIS OF HEPARIN INDUCED THROMBOCYTOPENIA: HELP OR HINDRANCE?
|
| Hammond S., Langley K., Smith G., Lahoz C., Dale C., Bevan S., MacCallum P. |
| |
|
LABORATORY DIAGNOSIS OF THE DISCREPANT PHENOTYPE OF MILD HAEMOPHILIA A USING A MODIFIED CHROMOGENIC FACTOR VIII ASSAY
|
| Duncan E.M., Rodgers S.E., Sobieraj-Teague M., Casey C.R., Lloyd J.V. |
| |
|
LABORATORY EVIDENCE OF HYPERFIBRINOLYSIS IN ASSOCIATION WITH LOW PAI-1 ACTIVITY
|
| Ågren A., Wiman B., Schulman S. |
| |
|
LABORATORY-DEFINED ASPIRIN RESISTANCE IS ASSOCIATED WITH A HIGHER RISK OF RECURRENT CARDIOVASCULAR EVENTS: A META-ANALYSIS
|
| Snoep J.D., Hovens M.M.C., Eikenboom J.C.J., van der Bom J.G., Huisman M.V. |
| |
|
LACK OF ASSOCIATION BETWEEN APOLIPOPROTEIN E POLYMORPHISM AND ATHEROMATOSIS EXTENT IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
|
| Lima L.M., Carvalho M.G., Sabino A.P., Fernandes A.P., Sousa M.O. |
| |
|
LACK OF ASSOCIATION OF ANTIPHOSPHOLIPID ANTIBODIES WITH CORONARY ATHEROSCLEROSIS IN PATIENTS UNDERGOING CORONARY ANGIOGRAPHY
|
| Hertzberg B., Charles P.C., Stouffer R., Wu S., Mapara S., Hilliard E., Lineberger R., Patterson C., Roubey R.A.S. |
| |
|
LACK OF EFFECT OF INFLUENZA IMMUNISATION ON ANTICOAGULANT CONTROL IN PATIENTS ON LONG-TERM WARFARIN
|
| MacCallum P.K., Madhani M., Mt-Isa S., Ashby D. |
| |
|
LACK OF EFFECT ON MARKERS OF THROMBIN GENERATION AND FIBRINOLYSIS BY PARTIAL FACTOR IXA INHIBITION FOLLOWING HIP FRACTURE SURGERY
|
| Dahl O.E., Eriksson B.I., Lassen M.R., Ward D.P., Rothlein R., Davis G., Turpie A.G.G. |
| |
|
LACK OF ENDOTHELIAL DYSFUNCTION IN THROMBOANGIITIS OBLITERANS
|
| Bura A., Boutouyrie P., Peyrard S., Fiessinger J.N., Laurent S., Azizi M. |
| |
|
LACK OF PREDICTIVE VALUE OF HIGH SHEAR PLATELET FUNCTION IN A POPULATION BASED COHORT STUDY OF ACUTE VASCULAR EVENTS
|
| Harrison P., Segal H., Silver L., Syed A., Rothwell P.M. |
| |
|
LACTADHERIN IS MORE SENSITIVE THAN ANNEXIN-V AT DETECTING PHOSPHATIDYLSERINE EXPOSURE WITHIN PLATELETS
|
| Albanyan A., Harrison P., Rasmussen J.T., Heegard C.W., Murphy M. |
| |
|
LATE BREAKING CLINICAL TRIAL: A DOSE FINDING STUDY OF THE ORAL DIRECT FACTOR XA INHIBITOR APIXABAN IN THE TREATMENT OF PATIENTS WITH ACUTE SYMPTOMATIC DEEP VEIN THROMBOSIS - THE BOTTICELLI INVESTIGATORS
|
| Buller H.R. |
| |
|
LATE BREAKING CLINICAL TRIAL: A LARGE-SCALE, GLOBAL OBSERVATIONAL STUDY OF VENOUS THROMBOEMBOLISM RISK AND PROPHYLAXIS IN THE ACUTE HOSPITAL CARE SETTING: THE ENDORSE STUDY
|
| Cohen A.T., Tapson V.F., Bergmann J.F., Goldhaber S.Z., Kakkar A.K., Anderson F.A. |
| |
|
LATE BREAKING CLINICAL TRIAL: ANTICOAGULANT CLINICS-BASED SHARED-CARE VERSUS GENERAL PRACTITIONERS MANAGEMENT OF ORAL ANTICOAGULANTS: A PROSPECTIVE, RANDOMIZED, CONTROLLED STUDY
|
| Bura A., Mismetti P., Quenet S., Cambus J., Boccalon H. |
| |
|
LATE BREAKING CLINICAL TRIAL: BIVALIRUDIN WITH AND WITHOUT EPTIFIBATIDE FOR ELECTIVE STENTING: A PHARMACODYNAMIC STUDY OF PLATELET REACTIVITY IN RELATION TO THE OCCURRENCE OF PERIPROCEDURAL MYOCARDIAL INFARCTION (THE CLEAR PLATELETS-2 STUDY)
|
| Gurbel P.A., Bliden K., DiChiara J., Herzog W., Cummings C., Dubois B.V., Gesheff T.B., Tantry U.S. |
| |
|
LATE BREAKING CLINICAL TRIAL: EXTENDED-DURATION VENOUS THROMBOEMBOLISM (VTE) PROPHYLAXIS IN ACUTELY ILL MEDICAL PATIENTS WITH RECENT REDUCED MOBILITY: THE EXCLAIM STUDY
|
| Hull R.D., Schellong S.M., Tapson V.F., Monreal M., Samama M.M., Turpie A.G.G., Yusen R.D. |
| |
|
LATE BREAKING CLINICAL TRIAL: RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND, MULTICENTER PHASE III STUDY TO ASSESS RFVIIA EFFICACY IN ACUTE INTRACEREBRAL HEMORRHAGE: THE FAST TRIAL
|
| Mayer S.A., Brun N.C., Begtrup K., Broderick J.P., Davis S.M., Diringer M.N., Skolnick B.E., Steiner T. |
| |
|
LATE BREAKING CLINICAL TRIAL: RIVAROXABAN AN ORAL, DIRECT FACTOR XA INHIBITOR FOR THE PREVENTION OF VENOUS THROMBOEMBOLISM IN TOTAL KNEE REPLACEMENT SURGERY: RESULTS OF THE RECORD 3 STUDY - LATE BREAKING
|
| Lassen M.R., Turpie A.G., Rosencher N., Borris L.C., Ageno W., Lieberman J.R., Bandel T.J., Misselwitz F. |
| |
|
LATE BREAKING CLINICAL TRIALS- BIOPHYSICAL INVESTIGATION OF A CONFORMATIONAL DISEASE: ANTITHROMBIN III AALBORG
|
| Pedersen S., Thomsen M., Kristensen S.R., Otzen D.E. |
| |
|
LDL ARE OXIDATIVELY MODIFIED BY PLATELETS VIA GP91PHOX
|
| Carnevale R., Pignatelli P., Lenti L., Buchetti B., Sanguigni V., Di Santo S., Violi F. |
| |
|
LDL-CHOLESTEROL ENHANCES PLATELET RECRUITMENT VIA GP91PHOX-MEDIATED CD40L UPREGULATION
|
| Pignatelli P., Di Santo S., Sanguigni V., Carnevale R., Muscolo V., Violi F. |
| |
|
LDL-INDUCED PLATELET ACTIVATION INVOLVES SPECIFIC DOMAINS IN APOB100
|
| Korporaal S.J.A., Buitrago Murcia L., Koekman A., Akkerman J.N. |
| |
|
LEPTIN INDUCES TISSUE FACTOR EXPRESSION IN HUMAN MONOCYTES
|
| Napoleone E., Di Santo A., Amore C., Baccante G., Di Febbo C., Porreca E., de Gaetano G., Donati M., Lorenzet R. |
| |
|
LEU335 CONTRIBUTES TO THE EFFICIENT PROTEOLYSIS OF FACTOR VIIIA AT ARG336 CATALYZED BY ACTIVATED PROTEIN C
|
| Varfaj F., Wakabayashi H., Fay P.J. |
| |
|
LEVEL OF PLASMA GLYCOCALICIN IN CHILDREN WITH THROMBOCYTOPENIA
|
| Ageenkova E.V., Sirotkina N.N., Petrov V.J., Soskov G.I., Vdovin V.V., Plahuta T.G. |
| |
|
LEVELS OF FACTOR VIII (FVIII), D-DIMER AND THROMBIN GENERATION (TG) IN PATIENTS AFTER ACUTE DEEP VEIN THROMBOSIS (DVT)
|
| ten Cate A.J., Dielis A.W.J.H., Spronk H.M.H., van Oerle R., Hamulyák K., Prins M.H., ten Cate H. |
| |
|
LIGAND-RECEPTOR AFFINITY AND RHO-FAMILIY GTPASES IN INTEGRIN ALPHA2BETA1-MEDIATED PROCESSES
|
| Smerling C., Farndale R.W. |
| |
|
LIMITED VERSUS EXTENDED ULTRASONOGRAPHY FOR THE DIAGNOSIS OF CLINICALLY SUSPECTED DEEP VEIN THROMBOSIS. A RANDOMIZED STUDY
|
| Bernardi E., Camporese G., Buller H.R., Siragusa S., Imberti D., Berchio A., Ghirarduzzi A., Verlato F., Anastasio R., Prati C., Piccioli A., Prandoni P. |
| |
|
LINKAGE ANALYSIS FOR NORMAL PROTEIN C LEVELS IN A PROTEIN C-DEFICIENT FAMILY
|
| Vossen C.Y., Hasstedt S.J., Rosendaal F.R., Demers C., Bovill E.G. |
| |
|
LIPID ALTERATIONS IN PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
|
| Mota A.P.L., Sousa M.O., Lima L.M., Santos M.E.R.C., Silva F.C.L., Carvalho M.G. |
| |
|
LIPID RAFT-DEPENDENT ACTIVATION OF NOVEL 33-KDA SER/THR KINASE IN THROMBIN-STIMULATED PLATELETS
|
| Ido M., Nakanishi K., Tanaka S., Bonno M., Yamamoto H., Komada Y., Gabazza E.C., Hayashi T., Suzuki K. |
| |
|
LIPID, INFLAMMATORY AND HAEMORHEOLOGICAL PROFILES ARE SIGNIFICANTLY AFFECTED BY FARMED FISH EATING: AN INTERVENTION STUDY
|
| Sofi F., Gori A., Cesari F., Paniccia R., Mannini L., Casini A., Parisi G., Giorgi G., Poli B., Abbate R., Gensini G. |
| |
|
LIPIDS, MICROPARTICLES AND COAGULATION FACTORS AS DETERMINANTS OF LAG PHASE AND RATE OF THROMBIN GENERATION IN PLASMA
|
| Kluft C., Meijer P., Kret R., Kaufmann V., Mager J., Binder B.R. |
| |
|
LIPOPROTEIN (A) AND VENOUS THROMBOEMBOLISM IN ADULTS: A META-ANALYSIS
|
| Sofi F., Marcucci R., Rogolino A., Alessandrello Liotta A., Cellai A., Fedi S., Mannini L., Abbate R., Gensini G., Prisco D. |
| |
|
LIPOPROTEIN(A) IN PATIENTS WITH CORONARY ARTERY DISEASE (CAD), ISCHEMIC STROKE (IS) AND PERIPHERAL ARTERIAL OBSTRUCTIVE DISEASE (PAOD)
|
| Lima L.M., Carvalho M.G., Sabino A.P., Mota A.P.L., Sousa M.O. |
| |
|
LIQUID HEPARIN ASSAY: RAPID MONITORING OF CLINICALLY USED HEPARINS
|
| Gabbeta J., Krougliak V., Quiazon E., Rawal D., Kung C., Triscott M. |
| |
|
LIVER AND SPLEEN MACROPHAGES CONTRIBUTE TO THE CLEARANCE OF VON WILLEBRAND FACTOR AND ITS COMPLEX WITH FACTOR VIII
|
| van Schooten C.J.M., Denis C.V., Oortwijn B.D., van den Berg M., de Groot P.G., Lenting P.J. |
| |
|
LIVING DONOR LIVER TRANSPLANTATION FOR HBV-ASSOCIATED HEPATOMA IN A HEMOPHILIC PATIENT
|
| Kim H.C., Wong H.J., Chung J.Y., Koh K.H. |
| |
|
LMWH BRIDGING FOR ELDERLY PATIENTS WITH ATRIAL FIBRILLATION
|
| Billett H.H., Madsen E.M., Giannattasio E.R. |
| |
|
LOCAL INTRAARTICULAR EXPRESSION OF FACTOR IX FROM ADENO-ASSOCIATED VIRUS (AAV) VECTORS PREVENTS DEVELOPMENT OF HEMOPHILIC ARTHROPATHY
|
| Sun J., Hakobyan N., Valentino L.A., Monahan P.E. |
| |
|
LOCAL ISI CALIBRATION AND "DIRECT INR" IN CORRECTION OF REPORTED INTERNATIONAL NORMALISED RATIOS: AN INTERNATIONAL STUDY
|
| Poller L., Keown M., Ibrahim S., van den Besselaar A.M.H.P., Roberts C., Stevenson K., Tripodi A., Pattison A., Jespersen J. |
| |
|
LOCAL THROMBOLYTIC THERAPY FOR ACUTE ILIOFEMORAL DEEP VENOUS THROMBOSIS IS EFFECTIVE AND PRESERVES VENOUS VALVE FUNCTION. A PROSPECTIVE ONE-CENTRE STUDY OF 86 CASES
|
| Joergensen M., Just S., Baekgaard N., Panduro L. |
| |
|
LOCALISATION OF COAGULATION PROTEINS WITHIN THE ARTERIAL VESSEL WALL IN RELATION TO PROGRESSION OF ATHEROSCLEROSIS
|
| Spronk H.M.H., van der Voort D., Heeneman S., Kassak P., Hamulyak K., Daemen M.J.A.P., ten Cate H. |
| |
|
LOCALIZATION AND EXPRESSION OF MYOSIN VI IN HUMAN HAEMATOPOIETIC CELLS INCLUDING PLATELETS
|
| Higashihara M., Usuda S., Miyazaki K., Watanabe M., Mohri H., Kawakami H. |
| |
|
LONG DISTANCE TRAVEL AND RISK OF VENOUS THROMBOSIS: EFFECT OF PROCOAGULANT FACTOR LEVELS
|
| Kuipers S., Cannegieter S.C., Doggen C.J.M., Büller H.R., Rosendaal F.R. |
| |
|
LONG LASTING ANTICOAGULANT EFFECTS OF ONCE WEEKLY SUBCUTANEOUS INJECTIONS OF IDRAPARINUX TO TREAT PATIENTS FOR PROPHYLAXIS OF RECURRENT VENOUS THROMBOEMBOLISM
|
| Harenberg J., Weiss C. |
| |
|
LONG TERM ANTICOAGULATION WITH FONDAPARINUX FOR DIALYSIS DEPENDENT PATIENT WITH HEPARIN-INDUCED THROMBOCYTOPENIA (HIT)
|
| Bermejo N., Martín Mateos M., Castellano I., Cámara C., Pardal E. |
| |
|
LONG TERM FOLLOW-UP OF LEVONORGESTREL-RELEASING INTRAUTERINE SYSTEM IN THE MANAGEMENT OF MENORRHAGIA IN WOMEN WITH INHERITED BLEEDING DISORDERS
|
| Chi C., Lee C., Shiltagh N., Kadir R.A. |
| |
|
LONG TERM OUTCOME AFTER DEEP VEIN THROMBOSIS
|
| Kahn S.R. |
| |
|
LONG TERM OUTCOMES AMONG PATIENTS UNDER THE AGE OF 55 YEARS WHO ARE DIAGNOSED WITH FIRST-TIME IDIOPATHIC PULMONARY EMBOLISM (PE)
|
| White R.H., Zhou H., Murin S. |
| |
|
LONG TERM OUTCOMES OF DEEP-VEIN THROMBOSIS IN ASIA AFTER MAJOR ORTHOPEDIC SURGERY: THE AIDA EXTENSION STUDY
|
| Piovella F., Barone M., Beltrametti C., Wang C.J., Lee L.H., Lee W.C., Turpie A.G., Gallus A.S., Planes A., Passera R. |
| |
|
LONG TERM RESULTS OF PULMONARY ENDARTERECTOMY (PEA) IN PATIENTS WITH CHRONIC THROMBOEMBOLIC PULMONARY HYPERTENSION (CTEPH). THE PAVIA ENDARTERECTOMY PROGRAM
|
| Piovella F., D'Armini A.M., Barone M., Beltrametti C., Emmi V., Viganò M. |
| |
|
LONGITUDINAL COURSE AND CLINICAL SIGNIFICANCE OF TGF-B1, SL- AND SE-SELECTINS AND SICAM-1 LEVELS DURING SEVERE ACUTE STRESS IN CHILDREN
|
| Papassotiriou I., Margeli A., Mavrikiou M., Lazaropoulou C., Briassoulis G. |
| |
|
LONGITUDINAL OBSERVATION OF TAFI LEVELS ALONG NORMAL PREGNANCY AND PUERPERIUM: RELATIONSHIP BETWEEN TAFI AND OTHER MARKERS OF FIBRINOLYSIS
|
| Karahan Yesil N., Demir M., Vural O., Varol F., Eskiocak M., Tokuc B., Tekgunduz E. |
| |
|
LONG-TERM OBSERVATION OF 280 PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS AND 74 PATIENTS WITH PRIMARY ANTIPHOSPHOLIPID SYNDROME: 10-YEAR FOLLOW-UP
|
| Reshetnyak T.M., Alexandrova E.N., Stivelband I.B., Novikov A.A., Nasonov E.L. |
| |
|
LONG-TERM PHARMACOVIGILANCE UPDATE WITH A RECOMBINANT FVIII CONCENTRATE FOR THE TREATMENT OF HEMOPHILIA A
|
| Oldenburg J., Petrini P., Faradji A., Tagliaferri A., Pabinger I., Knaub S., Zacharias C., Lenk H. |
| |
|
LONG-TERM PROGNOSIS OF PULMONARY EMBOLISM
|
| Meyer G., Sanchez O. |
| |
|
LONGTERM PROPHYLACTIC TREATMENT WITH FACTOR IX P IN A PATIENT WITH SEVERE CONGENITAL FACTOR X DEFICIENCY
|
| Zotz R.B., Scharf R.E., Gerhardt A. |
| |
|
LONGTERM PROPHYLACTIC TREATMENT WITH RECOMBINANT FACTOR VIIA (NOVOSEVEN) IN SEVERE CONGENITAL FACTOR VII DEFICIENT PATIENTS
|
| Zotz R.B., Scharf R.E., Gerhardt A. |
| |
|
LONG-TERM WARFARIN THERAPY IS ASSOCIATED WITH TISSUE CALCIFICATION: INFLUENCE OF TREATMENT DURATION, AGE, AND GENDER
|
| Whittaker P., Donovan J.L., Przyklenk K. |
| |
|
LOSS OF SEMA4D SIGNALING BETWEEN PLATELETS DESTABILIZES ARTERIAL THROMBI AND REDUCES MYOCARDIAL INFARCT SIZE
|
| Zhu L., Stalker T., Jiang H., Wang T., Gruber P., Brass L. |
| |
|
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH INCREASED LEVELS OF FVIII:C. A RETROSPECTIVE FAMILY COHORT STUDY
|
| van Vlijmen E.F.W., Coppens M., Veeger N.J.G.M., Middeldorp S., Hamulyák K., de Graeff P.A., Prins M.H., Büller H., van der Meer J. |
| |
|
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH MILD HYPERHOMOCYSTEINEMIA. A RETROSPECTIVE FAMILY COHORT STUDY
|
| van Vlijmen E.F.W., Coppens M., Veeger N.J.G.M., Middeldorp S., Karly Hamulyák K., Graeff P.A., Prins M.H., Harry Büller H.R., van der Meer J. |
| |
|
LOW ABSOLUTE RISK OF VENOUS THROMBOEMBOLISM (VTE) ASSOCIATED WITH ORAL CONTRACEPTIVES IN WOMEN WITH PROTHROMBIN 20210A. A RETROSPECTIVE FAMILY COHORT STUDY
|
| van Vlijmen E.F.W., Coppens M., Veeger N.J.G.M., Middeldorp S., Hamulyák K., de Graeff P.A., Prins M.H., Büller H.R., van der Meer J. |
| |
|
LOW ADAMTS13 LEVELS INCREASE THE RISK OF MYOCARDIAL INFARCTION (MI) INDEPENDENTLY OF VON WILLEBRAND FACTOR: GLASGOW MI STUDY
|
| Crawley J.T.B., Lane D.A., Rumley A., Woodward M., Lowe G.D. |
| |
|
LOW DOSE ACTIVATED PROTHROMBIN COMPLEX CONCENTRATE PROPHYLAXIS OF A PATIENT WITH ACQUIRED HAEMOPHILIA AFTER UNSUCCESSFUL ERADICATION THERAPY
|
| Schlammadinger A., Ilonczai P., Olah Z., Razso K., Boda Z. |
| |
|
LOW DOSE ANTICOAGULANT TREATMENT FOR PATIENTS WITH PERMANENT VENA CAVAL FILTERS
|
| Ceresetto J.M., Duboscq C., Shanley C., Stemmelin G., Rabinovich O., Doti C., Bottaro F., Emery N., Vicente M., Castedo G. |
| |
|
LOW HDL CHOLESTEROL AND LOW HDL TRIGLCERIDES IN PATIENTS WITH SYMPTOMATIC AND ASYMPTOMATIC HIGH GRADE INTERNAL CAROTID ARTERY STENOSIS
|
| Stojakovic T., Assadian A., Knöbl P., Hübl W., Senekowitsch C., Hagmüller G.W., Eidher U., Scharnagl H., Winkelmann B.R., Boehm B.O., März W. |
| |
|
LOW INCIDENCE OF INHIBITOR DEVELOPMENT IN PREVIOUSLY UNTREATED PATIENTS WITH HAEMOPHILIA A
|
| Klukowska A., Laguna P., Jansen M., Feddern J. |
| |
|
LOW INSULIN-LIKE GROWTH FACTOR (IGF) I, IGF BINDING PROTEIN-3 AND ACID LABILE SUBUNIT (ALS) LEVELS IN YOUNG ISCHEMIC STROKE: A PROSPECTIVE CASE-CONTROL STUDY
|
| Macarone Palmieri N., Tufano A., Di Somma C., Savanelli M.C., Di Capua M., De Gregorio A.M., De Simone C., Lombardi G., Di Minno M.N.D., Di Minno G., Colao A. |
| |
|
LOW INTENSITY LASER THERAPY SPEEDS WOUND HEALING IN HEMOPHILIA B MICE
|
| Hoffman M., McDonald A.G., Monroe D.M. |
| |
|
LOW LEVELS OF PROTEIN Z ARE ASSOCIATED WITH AN INCREASED RISK OF RECURRENT VASCULAR EVENTS: A POPULATION-BASED STUDY
|
| Segal H.C., Harrison P., Silver L.E., Syed A.B., Mehta Z., Keeling D.M., Rothwell P.M. |
| |
|
LOW MOLECULAR THIOLS, PRO-COAGULANT STATE AND NATURAL ANTIOXIDANT SYSTEM IN HEMODIALYSIS PATIENTS
|
| Alberto F., Hendler M.F., Meschengieser S.S., Bernasconi A., Heguilen R., Lazzari M.A. |
| |
|
LOW MOLECULAR WEIGHT HEPARIN (LMWH) AND CANCER SURVIVAL. A META-ANALYSIS OF RANDOMIZED CLINICAL TRIALS IN PATIENTS WITH AND WITHOUT VTE
|
| Laporte S., Meyer G., Buller H., Decousus H., Moulin N., Cucherat M., Mismetti P. |
| |
|
LOW MOLECULAR WEIGHT HEPARIN (LMWH) BRIDGING THERAPY DURING SUBTHERAPEUTIC INR LEVELS IN VTE HIGH RISK PATIENTS
|
| Testa S., Alatri A., Paoletti O. |
| |
|
LOW MOLECULAR WEIGHT HEPARIN (LMWH) DALTEPARIN REDUCES THE PROTHROMBOTIC AND PROANGIOGENIC POTENTIAL OF MICROVASCULAR ENDOTHELIAL CELLS ELICITED BY TUMOR CELLS
|
| Vignoli A., Marchetti M., Russo L., Balducci D., Falanga A. |
| |
|
LOW MOLECULAR WEIGHT HEPARIN IN PATIENTS WITH RENAL INSUFFICIENCY: ANALYSIS OF ANTI-XA LEVELS AND CREATININE CLEARANCE
|
| Lim W., Wang L., Sridhara M., Wang M., Douketis J., Rodger M., Crowther M. |
| |
|
LOW MOLECULAR WEIGHT HEPARIN IN PREGNANCY - INFLUENCE ON BIRTH WEIGHT AND DURATION OF PREGNANCY IN WOMEN WITH THROMBOPHILIA
|
| Klamroth R., Gottstein S., Essers E., Fischer J., Joschko K., Landgraf H. |
| |
|
LOW MOLECULAR WEIGHT HEPARINS ARE EFFECTIVE AND SAFE IN THROMBOPROPHYLAXIS IN NEWLY DIAGNOSED MYELOMA PATIENTS DURING THE INDUCTION THERAPY
|
| Kessler P., Pour L., Gregora E., Zemanova M., Penka M., Gumulec J., Adam Z., Bacovsky J., Brejcha M., Fenclova M., Frankova H., Havlikova K., Hausdorf P., Heindorfer A., Heinzova V., Holikova M., Krejci M., Kubackova K., Langrova E., Lehanka F., Maisnar V., Meluzinova I., Stavarova Y., Straub J., Svobodnik A., Scudla V., Sumna E., Ullrychova J., Walterova L., Hajek R. |
| |
|
LOW RESPONSIVENESS TO CLOPIDOGREL AND STENT THROMBOSIS
|
| Buonamici P., Marcucci R., Migliorini A., Paniccia R., Santini A., Gori A., Moschi G., Gensini G., Abbate R., Antoniucci D. |
| |
|
LOW-DOSE (1.2MG) RFVIIA TO REVERSE WARFARIN THERAPY IN CRITICALLY ILL PATIENTS WITH MAJOR BLEEDING
|
| Dager W.E., King J.H., Gosselin R.C., Regalia R.C., Rivera P., Williamson D., Owings J.T., White R.H. |
| |
|
LOW-DOSE ASPIRIN FOR SECONDARY PROPHYLAXIS OF VEIN THROMBOSIS (THE ASPIRE STUDY) BASELINE CHARACTERISTICS AND EVENT RATES FROM THE FIRST 380 PATIENTS
|
| Brighton T.A., Eikelboom J.W., Mister R., Hague W., Chinchen S., Kirby A., Gallus A., Ockelford P., Baker R., Coughlin P., Gibbs H., Becattini C., Agnelli G., Prandoni P., Simes J. |
| |
|
LOW-DOSE IMMUNE TOLERANCE INDUCTION IN THE TREATMENT OF PEDIATRIC HEMOPHILIA A PATIENTS WITH FACTOR VIII INHIBITORS-TURKISH EXPERIENCE
|
| Unuvar A., Kavakli K., Oren H., Vergin C., Meral A., Sayli T.R., Celkan T., Ucar C., Gursel T. |
| |
|
LOW-INTENSITY (INR TARGET 1,8) VERSUS STANDARD ANTICOAGULATION FOR STROKE PREVENTION IN NONVALVULAR ATRIAL FIBRILLATION: A RANDOMIZED SINGLE CENTRE STUDY IN ELDERLY PATIENTS
|
| Cucchini U., Pegoraro C., Osto E., Marzot F., Rampado E., Stendardo A., Pengo V. |
| |
|
LOW-MOLECULAR-WEIGHT HEPARIN IN THE ELDERLY WITH IMPAIRED RENAL FUNCTION
|
| Lim W., Crowther M.A. |
| |
|
LPS-STIMULATED MONOCYTES INHIBIT FIBRINOLYSIS THROUGH A TISSUE FACTOR (TF)-DEPENDENT, TAFI-MEDIATED MECHANISM
|
| Semeraro F., Ammollo T.C., Rossiello M.R., Rotunno C., Semeraro N., Colucci M. |
| |
|
LUNG INFLAMMATION AND THROMBOGENIC RESPONSES IN A TIME COURSE STUDY OF WILD TYPE AND REPAIR DEFECTIVE CSB
|
| Kooter I.M., Frederix K., Cassee F.R., van Oerle R., Spronk H.M.H., ten Cate H. |
| |
|
LUPUS ANTICOAGULANT: LABORATORY DIAGNOSIS FROM PATIENTS WITH THROMBOSIS
|
| Kobiljanskaja V.A. |
| |
|
LYMPHOCYTE PLATELET ADHESION IN THROMBOPHILIC PATIENTS WITH LUNG SURGERY
|
| Bogdanov I.G., Bogdanova A.S., Dimova S.N., Ryabchenko A.M., Vitkovsky Y.A. |
| |
|
LYMPHOCYTE-PLATELET ADHESION IN PATIENTS WITH ANGINA PECTORIS
|
| Solpov A.V., Zherebcova S.V., Govorin A.V., Rutskina E.A., Suvorova I.A., Vitkovsky Y.A. |
| |
|
LYSINE RESIDUES 2065 AND 2092 OF THE FACTOR VIII C1 DOMAIN CONTRIBUTE TO BINDING LRP AND LDL RECEPTOR, BUT ARE NOT INVOLVED IN BINDING FACTOR IXA
|
| Meems H., Limburg V., Meijer A.B., Mertens K. |
| |
